Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway.

Zeldin DC, Moomaw CR, Jesse N, Tomer KB, Beetham J, Hammock BD, Wu S.

Arch Biochem Biophys. 1996 Jun 1;330(1):87-96.

PMID:
8651708
2.

Cytochrome P450 pathways of arachidonic acid metabolism.

Kroetz DL, Zeldin DC.

Curr Opin Lipidol. 2002 Jun;13(3):273-83. Review.

PMID:
12045397
3.

Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases.

Oliw EH.

Prog Lipid Res. 1994;33(3):329-54. Review.

PMID:
8022846
4.

Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases.

Capdevila JH, Falck JR.

Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:325-44. Review.

PMID:
12432927
5.

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.

Spector AA, Fang X, Snyder GD, Weintraub NL.

Prog Lipid Res. 2004 Jan;43(1):55-90. Review.

PMID:
14636671
6.

The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.

Xu X, Zhang XA, Wang DW.

Adv Drug Deliv Rev. 2011 Jul 18;63(8):597-609. doi: 10.1016/j.addr.2011.03.006. Epub 2011 Apr 6. Review.

PMID:
21477627
7.

Cytochrome P-450 metabolites of arachidonic acid: implications for blood pressure regulation.

Carroll MA, Escalante B, McGiff JC.

Pol J Pharmacol Pharm. 1990 May-Jun;42(3):191-201. Review.

PMID:
2124686
8.

Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.

Shahabi P, Siest G, Visvikis-siest S.

Drug Metab Rev. 2014 Feb;46(1):33-56. doi: 10.3109/03602532.2013.837916. Epub 2013 Sep 16. Review.

PMID:
24040964
9.

Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

Theken KN, Lee CR.

Pharmacogenomics. 2007 Oct;8(10):1369-83. Review.

PMID:
17979511
10.

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.

Zordoky BN, El-Kadi AO.

Pharmacol Ther. 2010 Mar;125(3):446-63. doi: 10.1016/j.pharmthera.2009.12.002. Epub 2010 Jan 20. Review.

PMID:
20093140
11.

Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system.

Makita K, Falck JR, Capdevila JH.

FASEB J. 1996 Nov;10(13):1456-63. Review.

PMID:
8940291
12.

The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.

Fleming I.

Vascul Pharmacol. 2016 Nov;86:31-40. doi: 10.1016/j.vph.2016.03.001. Epub 2016 Mar 11. Review.

PMID:
26975734
13.

Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

Spector AA, Kim HY.

Biochim Biophys Acta. 2015 Apr;1851(4):356-65. doi: 10.1016/j.bbalip.2014.07.020. Epub 2014 Aug 2. Review.

14.
15.

Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.

Shahabi P, Siest G, Meyer UA, Visvikis-Siest S.

Pharmacol Ther. 2014 Nov;144(2):134-61. doi: 10.1016/j.pharmthera.2014.05.011. Epub 2014 Jun 2. Review.

PMID:
24882266
16.

Cytochrome P450 epoxygenases as EDHF synthase(s).

Fleming I.

Pharmacol Res. 2004 Jun;49(6):525-33. Review.

PMID:
15026030
17.

Biochemical and molecular characteristics of the cytochrome P450 arachidonic acid monooxygenase.

Capdevila JH, Falck JR.

Prostaglandins Other Lipid Mediat. 2000 Aug;62(3):271-92. Review. No abstract available.

PMID:
10963794
18.
19.

The cytochrome P450 pathway in angiogenesis and endothelial cell biology.

Fleming I.

Cancer Metastasis Rev. 2011 Dec;30(3-4):541-55. doi: 10.1007/s10555-011-9302-3. Review.

PMID:
22009065
20.

The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.

Xu X, Li R, Chen G, Hoopes SL, Zeldin DC, Wang DW.

Adv Nutr. 2016 Nov 15;7(6):1122-1128. doi: 10.3945/an.116.012245. Print 2016 Nov. Review.

PMID:
28140329

Supplemental Content

Support Center